Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Lymphatic endothelial marker (human) monoclonal antibody (D2-40)

 
ENZ-ABS104A-0025 25 µg 225.00 USD
 
ENZ-ABS104A-0100 100 µg 475.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ENZ-ABS104

Product Specification

Alternative Name:Podoplanin, Aggrus, Glycoprotein 36, T1A
 
Clone:D2-40
 
Host:Mouse
 
Isotype:IgG1
 
Immunogen:This antibody was developed using M2A.
 
Species reactivity:Human
 
Applications:IHC, WB
 
Recommended Dilutions/Conditions:Each lot of this antibody is quality control tested by immunohistochemistry. For immunohistochemistry
on formalin-fixed paraffin-embedded tissue, a concentration range of 0.5 - 5.0 μg/ml is suggested. For
Western blotting, the suggested use of this reagent is 2.0 - 5.0 μg per ml. It is recommended that the
reagent be titrated for optimal performance for each application.
 
Purity Detail:Affinity purified.
 
Formulation:Liquid. In Phosphate-buffered solution, pH 7.2.
 
Shipping:Blue Ice Not Frozen
 
Long Term Storage:+4°C
 
Lymphatic endothelial marker (human) monoclonal antibody (D2-40) IHC
IHC staining of purified anti-Podoplanin (Lymphatic Endothelial Marker) antibody (clone D2-40) on formalin-fixed paraffin embedded human colon tissue.
Lymphatic endothelial marker (human) monoclonal antibody (D2-40) WB
Western blot analysis of cell lysates from HeLa using Podoplanin Mouse primary antibody and HRP Goat anti-Mouse secondary antibody.
Please mouse over
Lymphatic endothelial marker (human) monoclonal antibody (D2-40) IHC Lymphatic endothelial marker (human) monoclonal antibody (D2-40) WB

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Podoplanin
By biological activity:
Podoplanin Monoclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2020 Enzo Life Sciences, Inc.,